Skip to main content
. 2017 Apr 12;6(3):185–193. doi: 10.2217/cns-2016-0049

Table 2. . Type of second-line chemotherapy after first recurrence.

Second-line chemotherapy TTFields plus second-line chemotherapy (n = 144); n (%) Second-line chemotherapy alone (n = 60); n (%)
Bevacizumab:
– Monotherapy 61 (42) 26 (43)
– Combination therapy 18 (13) 4 (7)

Lomustine, carmustine, fotemustine 52 (36) 23 (38)

Temozolomide 25 (17) 7 (12)

Irinotecan 3 (2) 2 (3)

Carboplatin 3 (2) 1 (2)

Procarbazine 0 1 (2)

TTFields: Tumor-treating fields.